News
新聞與媒體
Poly Pharmaceuticals' Dopamine Hydrochloride Hydrochloride Injection Exported to the United States
Recently, the shipment ceremony of Dopamine Hydrochloride Injection to the United States was held in...
View details
Zhejiang Poly Pharmaceuticals' Injection and Solid Dosage Workshops Receive US FDA Certification
Zhejiang Poly Pharmaceuticals Co., Ltd. (hereinafter referred to as "Zhejiang Poly"), a wh...
View details
Poly Pharmaceuticals has successfully developed Ursodeoxycholic acid (UDCA) API and looks forward to exploring the global market together with you.
Poly Pharmaceuticals Successfully Develops Ursodeoxycholic Acid (UDCA) Raw MaterialPoly Pharmaceutic...
View details
Zhejiang Poly Pharmaceuticals Unleashes New Production Capacity - Oral Liquid Production Line Complies with US, EU, and Chinese GMP Requirements, Welcomes Collaboration of Domestic and International CDMO/CMO
Zhejiang Poly Pharmaceuticals is a wholly-owned subsidiary of Hainan Poly Pharmaceutical (stock code...
View details
Home